Clinical Study
In 2006, the Medical Advisory Board commissioned a medical study to determine
the effectiveness of the MaxErect on a group of 46 male patients who had recently undergone a complete removal of the prostate gland. The study took place over a period of 90 days and each man was given the MaxErect ED Eliminator Pack. A majority of the patients were using current conventional methods for treating erectile dysfunction (ED), including erection enhancing drugs, penile injections, VEDs (vacuum erection devices), etc.
Prior to the inclusion of the MaxErect, each man was asked to complete a standard questionnaire, the International Index of Erectile Function (IIED) questionnaire, on the effectiveness of his current treatment, level of sexual activity, satisfaction, etc. on a scale of 1-5. After the inclusion of the MaxErect for a period of 90 days, each man completed the IIEF questionnaire again.
Use of the MaxErect enabled the test group of patients to achieve normal erectile function during the test period with a score of 20.81 on the Erectile Dysfunction Scale. The same test group of patients prior to using the MaxErect, but using conventional restoration therapies were unable to achieve more than a score of 3.62 (Severe ED) on the Erectile Dysfunction Scale.
In addition to the improved physical sexual ability, MaxErect was effective in increasing the experience and pleasure, as well as confidence for all the men in this study. The men also experienced a greater satisfaction in their sex life as a whole and in the relationship with their partner. The results of this study will be published in early 2009 in The Journal of Sexual Medicine.
This chart shows the results of the IIEF-5 (erectile function domain), the portion of the complete IIEF Questionnaire that is most applicable to our study. The results of the remaining questions were remarkable as well.
To view more detailed results of the study, click here.
To view the article for medical publication, click here.
the effectiveness of the MaxErect on a group of 46 male patients who had recently undergone a complete removal of the prostate gland. The study took place over a period of 90 days and each man was given the MaxErect ED Eliminator Pack. A majority of the patients were using current conventional methods for treating erectile dysfunction (ED), including erection enhancing drugs, penile injections, VEDs (vacuum erection devices), etc. Prior to the inclusion of the MaxErect, each man was asked to complete a standard questionnaire, the International Index of Erectile Function (IIED) questionnaire, on the effectiveness of his current treatment, level of sexual activity, satisfaction, etc. on a scale of 1-5. After the inclusion of the MaxErect for a period of 90 days, each man completed the IIEF questionnaire again.
Use of the MaxErect enabled the test group of patients to achieve normal erectile function during the test period with a score of 20.81 on the Erectile Dysfunction Scale. The same test group of patients prior to using the MaxErect, but using conventional restoration therapies were unable to achieve more than a score of 3.62 (Severe ED) on the Erectile Dysfunction Scale.In addition to the improved physical sexual ability, MaxErect was effective in increasing the experience and pleasure, as well as confidence for all the men in this study. The men also experienced a greater satisfaction in their sex life as a whole and in the relationship with their partner. The results of this study will be published in early 2009 in The Journal of Sexual Medicine.
This chart shows the results of the IIEF-5 (erectile function domain), the portion of the complete IIEF Questionnaire that is most applicable to our study. The results of the remaining questions were remarkable as well.
To view more detailed results of the study, click here.
To view the article for medical publication, click here.
*Viagra is a registered trademark of Pfizer, Inc., Cialis is a registered trademark of Eli Lilly and Company, and Levitra is a registered trademark of Bayer Pharmaceuticals Corp.
